Sign inJoin waitlistJoin the waitlist

KN

Kavita Natrajan

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Medical College of Georgia
2002–2005
Cooperman Barnabas Medical Center
1997–2000
Baroda Medical College
1990–1994

Research

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative…
Blood · 2009 · 152 citations
Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia
Review · Clinical Therapeutics · 2008 · Last of 3 authors · 141 citations
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Journal of Hematology & Oncology · 2013 · 81 citations

Celalettin Ustun
3 papers
Anand Jillella
2 papers
KB
Kapil Bhalla
2 papers
Abdullah Kutlar
1 paper
AS
Andrew Savoie
1 paper
Askiel Bruno
1 paper
BK
Bindu Kanapuru
1 paper
Daniel Chong
1 paper · 1 as a resident
DC
David Claxton
1 paper
David Hess
1 paper
DH
Douglas Hughes
1 paper · 1 as a resident
EW
Elliot Winton
1 paper